MEDP (NASDAQ) - Fundamental Data Analysis
VR Fundamental Rating 8.09
| VR Piotroski Score | 8.00 |
| Tobins Q Ratio | - |
| Free-Cash-Flow Yield | 4.35% |
| Free-Cash-Flow Margin | 21.20% |
| Net Margin | 15.33% |
| Gross Margin | 28.26% |
| Current Ratio | 0.53 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | 0.49 |
| Debt / Free-Cash Flow | 0.70 |
| Interest Expense / Debt | 0.04% |
| WACC | 8.90% |
| RoE Return on Equity | 58.01% |
| RoCE Return on Cap. Employed | 50.82% |
| RoA Return on Assets | 18.37% |
| RoIC Return on Inv. Cap. | 31.25% |
| Analysts Rating | 3.83 |
| Analysts Target Price (is below last close by |
269.50 USD -0.4%) |
VR Piotroski 8
| Yes: Net Income TTM (273.2m) > 10m and > 3% of Revenue TTM (3% = 53.4m) |
| Yes: FCF TTM (377.8m) > 1m and > FCF prev (97%) (276.9m) |
| Yes: RoA TTM 18.37% (Net Income TTM 273.2m / Total Assets 1486.7m) >3% and > RoA prev (97%) 13.28% (181.8m / 1328.4m) |
| Yes: Total Cash from Operating Activities TTM 413.7m > 1m and > Net Income TTM 273.2m |
| Yes: Net Debt (Debt 264.8m - CCE 95.2m) to EBITDA TTM (348.3m) ratio: 0.49 < 3.5 |
| No: Current Ratio 0.53 (Total Current Assets 448.9m / Total Current Liabilities 848.5m) >= 1 and > Current Ratio prev (97%) 0.41 (337.7m / 820.9m) |
| Yes: Shares Outstanding last quarter 31.8m < quarter 12m ago 32.3m |
| No: Gross Margin 28.26% (Total Revenue 1781.5m - Cost Of Revenue 1278.1m / Total Revenue) > 15% and > Gross Margin prev (97%) 0.29% |
| Yes: Asset Turnover 1.2 (Total Revenue 1781.5m / Total Assets 1486.7m) > Asset Turnover prev (97%) 1.0 (1374.5m / 1328.4m) |
| Yes: Interest Coverage Ratio 110.3 (EBITDA TTM 348.3m / Interest Expense TTM 3.2m) > 5 |
VR Altman -2.39
| -0.269 (A) = (Total Current Assets 448.9m - Total Current Liabilities 848.5m) / Total Assets 1486.7m |
| -0.968 (B) = Retained Earnings TTM -1439.1m / Total Assets 1486.7m |
| 0.218 (C) = EBIT TTM 324.3m / Total Assets 1486.7m |
| -1.499 (D) = Book Value of Equity -1522.8m / Total Liabilities 1015.8m |
| 1.198 (E) = Revenue TTM 1781.5m / Total Assets 1486.7m |
| Total Rating: -2.386 = (2.6 * A) + (1.5 * B) + (4.9 * C) + (0.95 * D) + (0.1 * E) |
Current Fundamental Values
Market Capitalization = 8517.1m USD
Market Capitalization in USD = 8517.1m (8517.1m USD * 1 USDUSD)
Revenue TTM = 1781.5m
Ebit TTM = 324.3m
Short Term Debt = 264.8m (by last quarter)
Debt = 264.8m (Short Term 264.785 + Long Term None)
CCE Cash And Equivalents = 95.2m (cash And Short Term Investments by last quarter)
Enterprise Value = 8686.7m (Market Cap 8517.1m + Debt 264.8m - CCE 95.2m)
Net Debt = 169.6m (264.8m Debt - 95.2m Cash and Cash Equivalents)
EBITDA = 348.3m (TTM)
FCF Yield = 4.35% (FCF TTM 377.8m / Enterprise Value 8686.7m)
FCF Margin = 21.2% (FCF TTM 377.8m / Revenue TTM 1781.5m)
Net Margin = 15.33% (Net Income TTM 273.2m / Revenue TTM 1781.5m)
Gross Margin = 28.26% ((Revenue TTM 1781.5m - Cost of Revenue TTM 1278.1m) / Revenue TTM)
Tobins Q-Ratio = -5.704 (Enterprise Value 8686.7m / Book Value Of Equity -1522.8m)
Interest Expense / Debt = 0.04% (Interest Expense 0.10m / Debt 264.8m)
Interest Coverage Ratio = 110.3 (EbitDA TTM 348.3m / Interest Expense TTM 3.16m)
Taxrate = 15.21% (Income Tax Expense 12.65m / Income Before Tax 83.20m, last quarter)
NOPAT Net Operating Profit after Tax = 276.4m (Operating Income TTM 325.9m * (1 - Taxrate 0.15))
Current Ratio = 0.53 (Total Current Assets 448.9m / Total Current Liabilities 848.5m)
Debt / Equity = 0.56 (Debt 264m / last Quarter total Stockholder Equity 470m)
Debt / EBITDA = 0.49 (Debt 264m - Cash and Cash Equivalents 95m / EBITDA 348m)
Debt / FCF = 0.70 (Debt 264m / FCF TTM 377m)
RoA = 18.37%
RoE = 58.01% (Net Income TTM 273m / Total Stockholder Equity 470m)
RoCE = 50.82% (Ebit TTM 324.3m / x)
RoIC = 31.25% (Ebit TTM 324.3m / (Total Assets 1487 m - Total Current Assets 448.9m) )
WACC = 8.90% ((Market Cap / EV) * CAPM 0.09) + (Debt / EV) * Interest Expense on Debt * (1 - Taxrate)
Shares Correlation 10-Years: -67.42 | Cagr: -2.19% (-1.48)
EPS Correlation 4-Years: 77.78 | EPS CAGR: 6.32%
Revenue Correlation 4-Years: 94.08 | Revenue CAGR: 4.74%
Market Capitalization in USD = 8517.1m (8517.1m USD * 1 USDUSD)
Revenue TTM = 1781.5m
Ebit TTM = 324.3m
Short Term Debt = 264.8m (by last quarter)
Debt = 264.8m (Short Term 264.785 + Long Term None)
CCE Cash And Equivalents = 95.2m (cash And Short Term Investments by last quarter)
Enterprise Value = 8686.7m (Market Cap 8517.1m + Debt 264.8m - CCE 95.2m)
Net Debt = 169.6m (264.8m Debt - 95.2m Cash and Cash Equivalents)
EBITDA = 348.3m (TTM)
FCF Yield = 4.35% (FCF TTM 377.8m / Enterprise Value 8686.7m)
FCF Margin = 21.2% (FCF TTM 377.8m / Revenue TTM 1781.5m)
Net Margin = 15.33% (Net Income TTM 273.2m / Revenue TTM 1781.5m)
Gross Margin = 28.26% ((Revenue TTM 1781.5m - Cost of Revenue TTM 1278.1m) / Revenue TTM)
Tobins Q-Ratio = -5.704 (Enterprise Value 8686.7m / Book Value Of Equity -1522.8m)
Interest Expense / Debt = 0.04% (Interest Expense 0.10m / Debt 264.8m)
Interest Coverage Ratio = 110.3 (EbitDA TTM 348.3m / Interest Expense TTM 3.16m)
Taxrate = 15.21% (Income Tax Expense 12.65m / Income Before Tax 83.20m, last quarter)
NOPAT Net Operating Profit after Tax = 276.4m (Operating Income TTM 325.9m * (1 - Taxrate 0.15))
Current Ratio = 0.53 (Total Current Assets 448.9m / Total Current Liabilities 848.5m)
Debt / Equity = 0.56 (Debt 264m / last Quarter total Stockholder Equity 470m)
Debt / EBITDA = 0.49 (Debt 264m - Cash and Cash Equivalents 95m / EBITDA 348m)
Debt / FCF = 0.70 (Debt 264m / FCF TTM 377m)
RoA = 18.37%
RoE = 58.01% (Net Income TTM 273m / Total Stockholder Equity 470m)
RoCE = 50.82% (Ebit TTM 324.3m / x)
RoIC = 31.25% (Ebit TTM 324.3m / (Total Assets 1487 m - Total Current Assets 448.9m) )
WACC = 8.90% ((Market Cap / EV) * CAPM 0.09) + (Debt / EV) * Interest Expense on Debt * (1 - Taxrate)
Shares Correlation 10-Years: -67.42 | Cagr: -2.19% (-1.48)
EPS Correlation 4-Years: 77.78 | EPS CAGR: 6.32%
Revenue Correlation 4-Years: 94.08 | Revenue CAGR: 4.74%